BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19482706)

  • 1. Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention.
    Cleary MP; Ray A; Rogozina OP; Dogan S; Grossmann ME
    Front Biosci (Schol Ed); 2009 Jun; 1(1):329-57. PubMed ID: 19482706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
    Grossmann ME; Ray A; Nkhata KJ; Malakhov DA; Rogozina OP; Dogan S; Cleary MP
    Cancer Metastasis Rev; 2010 Dec; 29(4):641-53. PubMed ID: 20821253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of obesity on breast cancer development.
    Cleary MP; Grossmann ME; Ray A
    Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol affects extracellular leptin:adiponectin ratio in human breast tissue in vivo.
    Morad V; Abrahamsson A; Dabrosin C
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3460-7. PubMed ID: 24796929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.
    Grossmann ME; Cleary MP
    Biochimie; 2012 Oct; 94(10):2164-71. PubMed ID: 22728769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer and obesity: in vitro interferences between adipokines and proangiogenic features and/or antitumor therapies?
    Dubois V; Delort L; Billard H; Vasson MP; Caldefie-Chezet F
    PLoS One; 2013; 8(3):e58541. PubMed ID: 23554900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and Adiponectin Modulate the Self-renewal of Normal Human Breast Epithelial Stem Cells.
    Esper RM; Dame M; McClintock S; Holt PR; Dannenberg AJ; Wicha MS; Brenner DE
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1174-83. PubMed ID: 26487401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tomato and soy on serum adipokine concentrations in postmenopausal women at increased breast cancer risk: a cross-over dietary intervention trial.
    Llanos AA; Peng J; Pennell ML; Krok JL; Vitolins MZ; Degraffinreid CR; Paskett ED
    J Clin Endocrinol Metab; 2014 Feb; 99(2):625-32. PubMed ID: 24423335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a walking intervention using mobile technology and interactive voice response on serum adipokines among postmenopausal women at increased breast cancer risk.
    Llanos AA; Krok JL; Peng J; Pennell ML; Vitolins MZ; Degraffinreid CR; Paskett ED
    Horm Cancer; 2014 Apr; 5(2):98-103. PubMed ID: 24435584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
    Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
    Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
    Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
    Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adiponectin and leptin co-treatment on human breast cancer cell growth.
    Nkhata KJ; Ray A; Schuster TF; Grossmann ME; Cleary MP
    Oncol Rep; 2009 Jun; 21(6):1611-9. PubMed ID: 19424644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers.
    Brown KA; Iyengar NM; Zhou XK; Gucalp A; Subbaramaiah K; Wang H; Giri DD; Morrow M; Falcone DJ; Wendel NK; Winston LA; Pollak M; Dierickx A; Hudis CA; Dannenberg AJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1692-1701. PubMed ID: 28323914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-Induced Dose-Response Alterations in Adiponectin and Leptin Levels Are Dependent on Body Fat Changes in Women at Risk for Breast Cancer.
    Sturgeon K; Digiovanni L; Good J; Salvatore D; Fenderson D; Domchek S; Stopfer J; Galantino ML; Bryan C; Hwang WT; Schmitz K
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1195-200. PubMed ID: 27197293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
    Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin and adiponectin: emerging therapeutic targets in breast cancer.
    Surmacz E
    J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):321-32. PubMed ID: 24136336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipokines and Vascular Endothelial Growth Factor in Normal Human Breast Tissue in Vivo - Correlations and Attenuation by Dietary Flaxseed.
    Morad V; Abrahamsson A; Kjölhede P; Dabrosin C
    J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):69-76. PubMed ID: 27059487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival.
    Lee SA; Sung H; Han W; Noh DY; Ahn SH; Kang D
    Asian Pac J Cancer Prev; 2014; 15(15):6137-43. PubMed ID: 25124587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin as a potential therapeutic target for breast cancer prevention and treatment.
    Ray A; Cleary MP
    Expert Opin Ther Targets; 2010 Apr; 14(4):443-51. PubMed ID: 20230196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
    Vona-Davis L; Rose DP
    Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.